MiniMed Group, Inc.(MMED)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-07-31.

MiniMed Group, Inc. (MMED) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MMED at 44.2/100 on a 32-signal composite quality model, placing it at rank #1,929 of 2,961 stocks — the bottom half of the AI-ranked universe. MMED scores in the top quartile across revenue growth (92.1). Areas of concern include profitability (30.0) and free cash flow (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), MiniMed Group, Inc. reports quarterly revenue of $843.0M, net income of $0.00, an operating margin of 0.6%. Top institutional holders of MMED by reported 13-F value include MASSACHUSETTS FINANCIAL SERVICES, MILLENNIUM MANAGEMENT, CITADEL ADVISORS, based on the most recent SEC filings. MMED trades on the Nasdaq exchange and files with the SEC under CIK 2062583. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MMED daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MiniMed Group, Inc. directly from SEC EDGAR.